DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fbrwb8/pcr_in_screening) has announced the addition of the "Global PCR in ...

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...

Digital PCR (dPCR) has emerged as a powerful tool in genetic analysis, offering improved precision, sensitivity, and accuracy compared to traditional methods. In this webinar, we will provide an ...

Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.

CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR platform, marking the first patent issued for this point-of-care technology.

DNA analysis is a crucial tool for identifying harmful pathogens, such as bacteria, viruses, or fungi, that cause infections.